Hand-foot syndrome.
Pike
K
K
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D005533:Foot Dermatoses / Q000139:chemically induced*; D006229:Hand Dermatoses / Q000139:chemically induced*; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010146:Pain / Q000139:chemically induced*; D010292:Paresthesia / Q000139:chemically induced*; D013577:Syndrome; D013997:Time Factors
D000970:Antineoplastic Agents; D004317:Doxorubicin